Concepedia
Statistics
Publications
14
Citations
580
H-Index
Active since
2016
Affiliations
Taipei Medical University(Current)
Taipei City Hospital
Taipei Medical University-Shuang Ho Hospital
Peng-Hsu Chen is an author at Taipei Medical University specializing in oncology, molecular oncology, and glioblastoma.
Publications per year
2016–2021
The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death
Peng-Hsu Chen, Cheng-Kuei Chang, Chwen-Ming Shih et al. · Neuropharmacology · 2016 · 77 citations
Life Sciences, Molecular Biology, Oncology +14
The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity
Peng-Hsu Chen, Wan-Lin Shen, Chwen‐Ming Shih et al. · Neuropharmacology · 2016 · 68 citations
Medicine, Cancer Biology, Oncology +14
A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas
Kuo-Hao Ho, Peng-Hsu Chen, Chih‐Ming Chou et al. · Neurotherapeutics · 2020 · 65 citations · Full text
Medicine, Molecular Biology, Oncology +17
The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death
Peng-Hsu Chen, Chia‐Hsiung Cheng, Chwen‐Ming Shih et al. · PLoS ONE · 2016 · 57 citations · Full text
Medicine, Oncology, Pharmacology +17
miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme
Kuo-Hao Ho, Chia‐Hsiung Cheng, Chih‐Ming Chou et al. · Pharmacological Research · 2019 · 46 citations
Medicine, Molecular Biology, Oncology +14
1–5 of 14